Best group on the street

What does the Sponsors group do? Haven't heard of that one before.

This thread is a few years old

This is one of many reasons, but read following from Reuters:

"The U.S. Treasury Department has hired Wall Street bankers and lawyers to advise on providing tens of billions of dollars in aid to the airline, cargo and defense sectors, people familiar with the matter said on Wednesday.

The appointments come after U.S. lawmakers approved a $2.2 trillion stimulus bill last week to mitigate the economic fallout of the coronavirus pandemic, which has killed more than 5,000 people in the United States and shut down large swathes of the country's economy.

PJT Partners Inc will advise the Treasury on its negotiations with the airlines, the sources said. The stimulus bill, known as the CARES Act, provides for up to $50 billion in aid to airlines, half of it in loans and loan guarantees and half of it in grants.

Goldman is the most active bank, all of their groups have a ton of activity. the thing is though that a lot of their groups are split into capital markets and M&A. so you could be in TMT but only do ecm / dcm

GS FIG does the most M&A work in proportion to the other groups at GS, due to the unique nature of FIG companies (not as much ECM activity and little to no DCM since FIG companies are already highly levered through deposits, policy liabilities, etc.)

not even true.. MS M&A has such a strong history of sending kids to amazing places that headhunters automatically trust the group. PJT RSSG is great too at that point what's the point of even comparing? Senior leadership at most PE/HFs are almost all from GS/MS, if that tells you anything.

PJT M&A is overrated on WSO. Would rather be at cvp, moe la, evr, hl rx

Lmao. That's their C-Suite

lol GS rx is a joke it’s glorified NPL workouts

PJT, HL, EVR, MoCo, Laz, etc.

Not on GS level at all. Something to note whenever people talk about any groups (but even moreso relevant for healthcare) is the VERTICAL. For instance, Centerview absolutely kills it in pharma and no one doubts that, but they can't say the same for medtech, services, HCIT, etc.

Back to your question, I'm assuming Menlo EVR HC would only focus on biotech / life sciences given the location. They're solid in the space but by no means at the top (GS / Centerview / JPM / MS all are better)

Truthfully just don't know enough about Moelis to put them on here (not in either a negative or positive way). 

It does seem like Moelis is just absolutely solid all around, but not sure if they would be a clear-cut industry #1 (or even 2/3) for any sector. Seems like their strategy the past few years has been to focus the majority of their time on smaller deals (e.g. sub $1bn), so maybe this plays a role? Tbh not entirely sure and don't want to say something that isn't true.